• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[获得性自身免疫性凝血因子 XIII/13缺乏症]

[Acquired autoimmune coagulation factor XIII/13 deficiency].

作者信息

Ogawa Yoshiyuki

机构信息

Department of Hematology, Gunma University Hospital.

出版信息

Rinsho Ketsueki. 2020;61(7):799-808. doi: 10.11406/rinketsu.61.799.

DOI:10.11406/rinketsu.61.799
PMID:32759568
Abstract

Coagulation factor XIII/13 (FXIII) is a transglutaminase that cross-links fibrin monomers, provides clot stabilization and resistance to fibrinolysis and proteolysis, and ultimately contributes to hemostasis and wound healing. FXIII is a hetero-tetramer formed by two catalytic A subunits (FXIII-A) and two noncatalytic B subunits (FXIII-B). Autoimmune acquired factor XIII/13 deficiency secondary to anti-FXIII antibodies (AH13) is a severe bleeding disorder that occurs mainly in the elderly. While AH13 is a very rare disease, with only about 100 cases reported worldwide, more than 60 of these cases have been identified in Japan. AH13 is somewhat difficult to diagnose because the abnormalities are not detected by routine coagulation testing. Anti-FXIII autoantibodies have been sub-classified into three types, including: (1) type Aa autoantibodies that mainly inhibit the thrombin-mediated proteolytic cleavage of FXIII-A, preventing its activation, (2) type Ab autoantibodies that inhibit the enzymatic activity of activated FXIII-A, and (3) type B autoantibodies that bind to and remove noncatalytic FXIII-B subunits from the circulation. We have encountered four cases of AH13 (three of type Aa and one of type B) in the past decade. This review outlines the diagnosis and treatment of AH13, with a focus on recent experience at our hospital.

摘要

凝血因子 XIII/13(FXIII)是一种转谷氨酰胺酶,可使纤维蛋白单体交联,提供凝块稳定性并抵抗纤维蛋白溶解和蛋白水解,最终有助于止血和伤口愈合。FXIII 是一种异源四聚体,由两个催化性 A 亚基(FXIII-A)和两个非催化性 B 亚基(FXIII-B)组成。继发于抗 FXIII 抗体(AH13)的自身免疫性获得性因子 XIII/13 缺乏症是一种主要发生在老年人中的严重出血性疾病。虽然 AH13 是一种非常罕见的疾病,全球仅报告了约 100 例,但其中 60 多例在日本被确诊。AH13 somewhat difficult to diagnose because the abnormalities are not detected by routine coagulation testing. 抗 FXIII 自身抗体已被分为三种类型,包括:(1)主要抑制凝血酶介导的 FXIII-A 蛋白水解裂解从而阻止其活化的 Aa 型自身抗体,(2)抑制活化的 FXIII-A 酶活性的 Ab 型自身抗体,以及(3)结合并从循环中清除非催化性 FXIII-B 亚基的 B 型自身抗体。在过去十年中,我们遇到了 4 例 AH13(3 例 Aa 型和 1 例 B 型)。本综述概述了 AH13 的诊断和治疗,重点介绍了我院的近期经验。 (注:原文中“AH13 is somewhat difficult to diagnose because the abnormalities are not detected by routine coagulation testing.”此句中“somewhat”翻译时位置有误,正确译文应是:AH13 有些难以诊断,因为常规凝血检测无法检测到异常。)

相似文献

1
[Acquired autoimmune coagulation factor XIII/13 deficiency].[获得性自身免疫性凝血因子 XIII/13缺乏症]
Rinsho Ketsueki. 2020;61(7):799-808. doi: 10.11406/rinketsu.61.799.
2
[Diagnosis and treatment of acquired factor XIII/13 deficiencies: for all doctors treating the MHLW's designated intractable diseases].获得性凝血因子 XIII/13 缺乏症的诊断与治疗:面向所有治疗厚生劳动省指定难治性疾病的医生
Rinsho Ketsueki. 2015 Oct;56(10):2110-22. doi: 10.11406/rinketsu.56.2110.
3
Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.用于检测抗凝血因子 XIII A 亚基抗体的快速免疫层析试验可诊断 90% 的自身免疫性血友病 XIII/13 病例。
Thromb Haemost. 2015 Jun;113(6):1347-56. doi: 10.1160/TH14-09-0745. Epub 2015 Mar 5.
4
Anti-factor XIII A subunit (FXIII-A) autoantibodies block FXIII-A2 B2 assembly and steal FXIII-A from native FXIII-A2 B2.抗因子 XIII A 亚单位 (FXIII-A) 自身抗体可阻止 FXIII-A2B2 的组装,并从天然的 FXIII-A2B2 中窃取 FXIII-A。
J Thromb Haemost. 2015 May;13(5):802-14. doi: 10.1111/jth.12877. Epub 2015 Apr 2.
5
Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies.由抗凝血因子 XIII 抗体引起的侵袭性致命性自身免疫性血友病病例。
Blood Coagul Fibrinolysis. 2013 Jan;24(1):85-9. doi: 10.1097/MBC.0b013e328358e8e7.
6
Successful Management of a Patient with Autoimmune Hemorrhaphilia due to Anti-Factor XIII/13 Antibodies Complicated by Pulmonary Thromboembolism.抗因子 XIII/13 抗体所致自身免疫性血友病合并肺血栓栓塞症患者的成功管理
Acta Haematol. 2017;137(3):141-147. doi: 10.1159/000455938. Epub 2017 Apr 6.
7
Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited and acquired forms.凝血因子 XIII 缺乏症。遗传性和获得性形式的诊断、患病率及管理。
Hamostaseologie. 2014;34(2):160-6. doi: 10.5482/HAMO-13-08-0046. Epub 2014 Feb 7.
8
Pathological coagulation parameters in as many as 54 patients with autoimmune acquired factor XIII deficiency due to anti-factor XIII autoantibodies.多达 54 例因抗因子 XIII 自身抗体所致自身免疫获得性因子 XIII 缺乏症患者的病理凝血参数。
Haemophilia. 2021 May;27(3):454-462. doi: 10.1111/hae.14298. Epub 2021 Apr 12.
9
Successful bypass surgery for esophageal carcinoma under adequate factor XIII/13 replacement therapy in a case of intractable autoimmune hemorrhaphilia due to anti-Factor XIII/13 antibodies.在一例因抗凝血因子 XIII/13 抗体导致的难治性自身免疫性血友病患者中,在充分的凝血因子 XIII/13 替代治疗下成功进行了食管癌搭桥手术。
Int J Hematol. 2016 Mar;103(3):341-7. doi: 10.1007/s12185-015-1917-7. Epub 2015 Nov 30.
10
Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.凝血因子 XIII:先天性凝血因子 XIII 缺乏症,获得性凝血因子 XIII 缺乏症,凝血因子 XIII A 亚单位,和凝血因子 XIII B 亚单位。
Arch Pathol Lab Med. 2014 Feb;138(2):278-81. doi: 10.5858/arpa.2012-0639-RS.

引用本文的文献

1
Acquired factor XIII deficiency presenting with multiple intracranial hemorrhages and right hip hematoma: A case report.获得性因子 XIII 缺乏症伴多发颅内出血和右髋部血肿:一例报告。
World J Radiol. 2024 Sep 28;16(9):439-445. doi: 10.4329/wjr.v16.i9.439.
2
A Case of Acquired Factor XIII Deficiency with Systemic Lupus Erythematosus Diagnosed after Repeated Intracerebral Hemorrhages.一例反复脑出血后诊断为系统性红斑狼疮伴获得性因子 XIII 缺乏症的病例
NMC Case Rep J. 2023 May 17;10:121-124. doi: 10.2176/jns-nmc.2022-0373. eCollection 2023.